Spyre Therapeutics (SYRE) Operating Leases (2019 - 2023)
Spyre Therapeutics' Operating Leases came in at $3.82 million for Q1 2023, down 14.4% from $4.47 million a year earlier and down 4.5% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Operating Leases (2019 - 2023) Analysis & Trends
At the end of FY2022, Spyre Therapeutics' Operating Leases was $4 million, down 13.1% from FY2021.
- Operating Leases carries a three-year compound annual growth rate of -5.3% (FY2019 to FY2022).
- Going back by year, Operating Leases was $4.61 million in FY2021 (-10.2%), $5.13 million in FY2020 (+8.8%) and $4.71 million in FY2019.
- The Q1 2023 figure represents the lowest quarterly Operating Leases since Q1 2019.
- Year-over-year, Operating Leases has declined for seven consecutive quarters, with an average decline of 9.1% over the last eight quarters.
- The fastest year-over-year change in Operating Leases over five years came in Q4 2020 (growth of 8.8%), and the weakest in Q1 2023 (a decline of 14.4%).
- Business Quant data shows SYRE's Operating Leases at $4 million (Q4 2022), $4.16 million (Q3 2022) and $4.32 million (Q2 2022) in the three quarters before Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Spyre Therapeutics | 7.46 Bn | 7.46 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 3.82 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 4.16 Mn |
| Jun 30, 2022 | 4.32 Mn |
| Mar 31, 2022 | 4.47 Mn |
| Dec 31, 2021 | 4.61 Mn |
| Sep 30, 2021 | 4.75 Mn |
| Jun 30, 2021 | 4.88 Mn |
| Mar 31, 2021 | 5.01 Mn |
| Dec 31, 2020 | 5.13 Mn |
| Sep 30, 2020 | 4.95 Mn |
| Jun 30, 2020 | 4.70 Mn |
| Mar 31, 2020 | 4.82 Mn |
| Dec 31, 2019 | 4.71 Mn |
| Sep 30, 2019 | 4.87 Mn |
| Jun 30, 2019 | 4.82 Mn |
| Mar 31, 2019 | 372,000.00 |
API Access
Spyre Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();